Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
126,442Documents
700Full text
2026-09-16Last indexed
Recent documents from this source
- Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm#349954
- Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma#349953
- BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma#349952
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas#349951
- Study With Candida Antigen for Treatment of Warts#349950
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.#349949
- MB-CART19.1 in Patients With R/R ALL#349948
- A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors#349947
- A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma#349946
- CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas#349945
- Neoadj Admin Autologous Tumor Infiltrating Lymphocytes & Pembrolizumab for Treatment of Adv Melanoma Patients#349944
- Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies#349943
- Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer#349942
- Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma#349941
- Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.#349940
- Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)#349939
- Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)#349938
- Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin#349937
- A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM#349936
- Metformin for the Treatment of Unexplained Oligozspermia#349935
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).